Biotech Finance refers to the financial management, investment strategies, and capital allocation specific to the biotechnology sector. This field encompasses the funding of biotech companies that develop drugs, therapies, and technologies derived from biological systems. It involves analyzing the financial health and potential of biotech firms, which often require significant investment to fund research and development due to lengthy and costly clinical trials and regulatory processes.
Biotech Finance also includes venture capital funding, public offerings, and private equity, focusing on how these entities can finance innovations and bring them to market. Investors and financial professionals in this sector must understand both the scientific aspects of biotechnology and the financial metrics that indicate company performance and risks. The goal is to maximize returns while managing the unique challenges of the biotech industry, including high failure rates for new drugs and fluctuating market conditions.
BioNTech faces reduced profits and revenues after pandemic vaccine demand subsides. The company reported a net loss of approximately €700 million in 2024 with income per share at €1.08. Future…